Key result
Advancements in 2019 for arrhythmias and pacing included new ESC guidelines for supraventricular tachycardia, updated atrial fibrillation risk assessments, and evolving evidence for catheter ablation.
Provides a comprehensive overview of the key clinical trials, guidelines, and technological advancements in the field of arrhythmias and pacing during 2019.
AF advances may inform current management; leaves open research needs for ventricular arrhythmias and devices.
During this last year, there has been much progress with regard to anticoagulant and ablation therapy for atrial fibrillation (AF). Apart from recently issued European Society of Cardiology Guidelines for the management of patients with supraventricular arrhythmias, there has been little progress in research in this field. Ventricular arrhythmias and device therapy have seen modest progress.
No takes yet. Share an insight, caveat, or question.
Camm et al. (2020) conducted a review in Arrhythmias and pacing. Cardiology advancements in 2019 was evaluated. Advancements in 2019 for arrhythmias and pacing included new ESC guidelines for supraventricular tachycardia, updated atrial fibrillation risk assessments, and evolving evidence for catheter ablation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: